A patient presents with acute poisoning: miosis (pinpoint pupils), respiratory depression, loss of consciousness, and decreased bowel sounds. Urine immunoassay is positive for opioids. When naloxone is administered, the patient awakens immediately but becomes extremely agitated. After 45 minutes, the patient again becomes unresponsive. What accounts for this recurrence?
- A Naloxone caused paradoxical opioid receptor sensitization
- B Naloxone is metabolized by CYP3A4 — genetic variation reduces its effectiveness
- C The opioid involved (likely methadone or buprenorphine) has a longer half-life than naloxone, requiring repeated dosing or infusion ✓
- D Tolerance to naloxone developed within 45 minutes
Explanation
Naloxone has a short half-life of 60–90 minutes. When used to reverse poisoning by long-acting opioids such as methadone (half-life 24–48 hours) or long-acting opioid preparations, the naloxone's effect wears off before the opioid is eliminated, causing renarcotization (re-emergence of opioid toxicity). Management requires either repeated bolus doses of naloxone every 30–60 minutes or a continuous naloxone infusion (typically 2/3 of the reversal dose per hour). Agitation on awakening reflects sudden precipitation of acute opioid withdrawal in a dependent patient. This is a critical clinical concept in emergency and forensic medicine for opioid overdose management.
Reference: The Essentials of Forensic Medicine and Toxicology (Narayan Reddy), 34th ed.
High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP
Written and medically reviewed by the StethoPrep medical team.